Pharmafox Therapeutics Ag

Pharmafox Therapeutics Ag company information, Employees & Contact Information

PharmaFox develops innovative compounds until clinical phase 1/2 for the pharmaceutical market. As soon as the early development phase is completed PharmaFox expects interest from Pharma companies. In this case it is foreseen that the assets will be sold. Investing in PharmaFox is a relatively low risk investment and can generate a high upside potential. The innovative pharma approach applied by the founders is already substantially de-risked. The companies lead compound is active in a high profile muscle disease (sarcopenia) making an early sale with an attractive deal probable. The ultimate goal of the investments is to create an optimal and realistic exit opportunity.

Company Details

Employees
2
Founded
-
Address
Möhlin, Aargau
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Möhlin, aargau
Looking for a particular Pharmafox Therapeutics Ag employee's phone or email?

Pharmafox Therapeutics Ag Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant